Otonomy Announces Pricing of $60.1 Million Public Offering

Back to Jobs

SAN DIEGO , July 09, 2020 (GLOBE NEWSWIRE) — Otonomy , Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced the pricing of an underwritten public offering of 14,500,000 shares of its common stock at a price to the

Apply Now